Exact Mass: 613.2153178000001

Ferrioxamine B

C25H45FeN6O8 (613.26481)

Ferrioxamine b belongs to the class of organic compounds known as n-acyl amines. N-acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Ferrioxamine b is considered to be a practically insoluble (in water) and relatively neutral molecule. Ferrioxamine b exists in all living organisms, ranging from bacteria to humans.

Neoacrimarine E

C35H35NO9 (613.23117)

Neoacrimarine E is found in citrus. Neoacrimarine E is an alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) and Dancy tangerine (Citrus tangerina)] (Rutaceae). Alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) and Dancy tangerine (Citrus tangerina)] (Rutaceae). Neoacrimarine E is found in citrus.

Pervilleine D

C32H39NO11 (613.2522984)

SCHEMBL1875255

C30H30F7N3O3 (613.2175274)

C28H39NO14

C28H39NO14 (613.2370434)

C24H39NO17

C24H39NO17 (613.2217884)

Myrsinol-type diterpene ester CPB51-719-2

C32H39NO11 (613.2522984)

Mosapride citrate

C27H33ClFN3O10 (613.18384)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D005765 - Gastrointestinal Agents Mosapride citrate is an orally active gastroenterokinetic compound. Mosapride citrate is a 5HT4 agonist. Mosapride citrate is a CYP inducer. Mosapride citrate has a concentration-dependent inhibitory effect on Kv4.3, and its IC50 value is 15.2 μM. Mosapride citrate can be used in the study of gastrointestinal diseases[1][2][3][4][5][6][7].

Ferrioxamine B [M+Fe-2H]

C25H45FeN6O8 (613.26481)

Asp Phe Phe Trp

C33H35N5O7 (613.253636)

Asp Phe Trp Phe

C33H35N5O7 (613.253636)

Asp Met Trp Tyr

C29H35N5O8S (613.220623)

Asp Met Tyr Trp

C29H35N5O8S (613.220623)

Asp Trp Phe Phe

C33H35N5O7 (613.253636)

Asp Trp Met Tyr

C29H35N5O8S (613.220623)

Asp Trp Tyr Met

C29H35N5O8S (613.220623)

Asp Tyr Met Trp

C29H35N5O8S (613.220623)

Asp Tyr Trp Met

C29H35N5O8S (613.220623)

Phe Asp Phe Trp

C33H35N5O7 (613.253636)

Phe Asp Trp Phe

C33H35N5O7 (613.253636)

Phe Phe Asp Trp

C33H35N5O7 (613.253636)

Phe Phe Trp Asp

C33H35N5O7 (613.253636)

Phe Met Met Trp

C30H39N5O5S2 (613.2392484000001)

Phe Met Trp Met

C30H39N5O5S2 (613.2392484000001)

Phe Trp Asp Phe

C33H35N5O7 (613.253636)

Phe Trp Phe Asp

C33H35N5O7 (613.253636)

Phe Trp Met Met

C30H39N5O5S2 (613.2392484000001)

Met Asp Trp Tyr

C29H35N5O8S (613.220623)

Met Asp Tyr Trp

C29H35N5O8S (613.220623)

Met Phe Met Trp

C30H39N5O5S2 (613.2392484000001)

Met Phe Trp Met

C30H39N5O5S2 (613.2392484000001)

Met Met Phe Trp

C30H39N5O5S2 (613.2392484000001)

Met Met Trp Phe

C30H39N5O5S2 (613.2392484000001)

Met Trp Asp Tyr

C29H35N5O8S (613.220623)

Met Trp Phe Met

C30H39N5O5S2 (613.2392484000001)

Met Trp Met Phe

C30H39N5O5S2 (613.2392484000001)

Met Trp Tyr Asp

C29H35N5O8S (613.220623)

Met Tyr Asp Trp

C29H35N5O8S (613.220623)

Met Tyr Trp Asp

C29H35N5O8S (613.220623)

Trp Asp Phe Phe

C33H35N5O7 (613.253636)

Trp Asp Met Tyr

C29H35N5O8S (613.220623)

Trp Asp Tyr Met

C29H35N5O8S (613.220623)

Trp Phe Asp Phe

C33H35N5O7 (613.253636)

Trp Phe Phe Asp

C33H35N5O7 (613.253636)

Trp Phe Met Met

C30H39N5O5S2 (613.2392484000001)

Trp Met Asp Tyr

C29H35N5O8S (613.220623)

Trp Met Phe Met

C30H39N5O5S2 (613.2392484000001)

Trp Met Met Phe

C30H39N5O5S2 (613.2392484000001)

Trp Met Tyr Asp

C29H35N5O8S (613.220623)

Trp Tyr Asp Met

C29H35N5O8S (613.220623)

Trp Tyr Met Asp

C29H35N5O8S (613.220623)

Tyr Asp Met Trp

C29H35N5O8S (613.220623)

Tyr Asp Trp Met

C29H35N5O8S (613.220623)

Tyr Met Asp Trp

C29H35N5O8S (613.220623)

Tyr Met Trp Asp

C29H35N5O8S (613.220623)

Tyr Trp Asp Met

C29H35N5O8S (613.220623)

Tyr Trp Met Asp

C29H35N5O8S (613.220623)

Neoacrimarine E

C35H35NO9 (613.23117)

Fmoc-Pen(Trt)-OH

C39H35NO4S (613.228667)

TAE684(NVP-TAE684)

C30H40ClN7O3S (613.260172)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

5-Trt-N6-Bz-rA

C36H31N5O5 (613.2325076)

N-[2-[4-[[[2-[(Hydroxyamino)carbonyl]-4,6-dimethylphenyl](phenylmethyl)amino]sulfonyl]phenoxy]ethyl]-2-benzofurancarboxamide

C33H31N3O7S (613.1882616)

N-Acetyl-N-[1-(1,1-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]-4-[difluoro(phosphono)methyl]phenylalaninamide

C31H34F2N3O6P (613.2153178000001)

131-hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester

C35H33MgN4O5- (613.2301328)

Euphorbia diterpenoid 2

C32H39NO11 (613.2522984)

A tetracyclic diterpenoid isolated from the whole plant of Euphorbia decipiens and exhibits inhibitory activity against urease.

1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea

C31H34F3N5O5 (613.251191)

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.251191)

N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.251191)

N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.251191)

N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide

C31H34F3N5O5 (613.251191)

N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide

C31H36FN3O7S (613.2257878)

O-[N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosaminyl]-L-threonine

C23H39N3O16 (613.2330214)

A non-proteinogenic L-alpha-amino acid that is N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine linked via an alpha glycosidic bond to the O at position 3 of L-threonine.

Ferroxamine

C25H45FeN6O8 (613.26481)

A Fe(III)-complexed hydroxamate siderophore comprising equimolar amounts of iron(3+) and desferrioxamine B(3-)

LNAPS 23:6;O

C29H44NO11P (613.2651844)

methyl (4s)-4-(3-acetyl-2,6-dihydroxyphenyl)-4-(3-{[(2s,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]methyl}-1h-indol-2-yl)-2-methoxybutanoate

C34H35N3O8 (613.2424030000001)

(3s,6s,7r)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2522984)

3,5,10,28-tetrahydroxy-7-methyl-26-oxo-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,22,27-nonaen-21-yl octa-2,4-dienoate

C34H31NO10 (613.1947866)

(13r,20r,21s,25s)-3,5,10,28-tetrahydroxy-7-methyl-26-oxo-14,16,19-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2,4,6,8,10,17,22,27-nonaen-21-yl (2e,4e)-octa-2,4-dienoate

C34H31NO10 (613.1947866)

(1r,3s,5s,6r,7s)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2522984)

1-hydroxy-4-[5-hydroxy-2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl]-3,5,6-trimethoxy-10h-acridin-9-one

C35H35NO9 (613.23117)

2,5-dihydroxy-10-(2-hydroxy-5-{2-hydroxy-4-[(4-hydroxy-3-methoxyphenyl)methyl]-5h-pyrrol-3-yl}phenyl)-6,8-dimethoxy-2-methyl-3h-naphtho[2,3-b]pyran-4-one

C34H31NO10 (613.1947866)

6-hydroxy-8-methyl-7-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate

C32H39NO11 (613.2522984)

1-hydroxy-4-[(4s)-5-hydroxy-2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl]-3,5,6-trimethoxy-10h-acridin-9-one

C35H35NO9 (613.23117)